{"id":"559134-9138","orgnr":"559134-9138","name":"PA Pharma Development AB","name_registered_on":"2018-09-14","legal_form":{"code":"AB","name":"Aktiebolag"},"status":"registered","registered_on":"2017-11-23","business_description":"Bolaget skall bidra och medvrka vid utveckling av nya produkiter inom life science samt därmed förenlig verksamhet.","industries":[{"code":"72109","name":"Annan naturvetenskaplig och teknisk forskning och utveckling"}],"postal_address":{"street":"Norrbyvretsvägen 4","care_of":"Paul Alhadeff","postal_code":"14763","city":"UTTRAN","country":"SE","municipality":{"code":"0127","name":"Botkyrka"},"county":{"code":"01","name":"Stockholms län"}},"registered_office":{"municipality":{"code":"0127","name":"Botkyrka"},"county":{"code":"01","name":"Stockholms län"}},"activity_status":"active","employee_class":{"code":"2","name":"1-4 anställda"},"turnover_class":{"code":"2","name":"500 - 999 tkr","year":2025},"f_tax":"registered","vat":"registered","employer":"registered","registry_source":{"dataset":"bolagsverket_bulkfil","published_on":"2026-11-09"},"annual_reports":[{"from":"2025-01-01","to":"2025-12-31","framework":"K2","signed_on":"2026-05-09","documents":{"annual_report":"/v1/documents/b6b30c57-4294-48e6-9d44-26f3a04e4338.xhtml"},"source":{"dataset":"arsredovisningar","file":"2026/20_3.zip"}},{"from":"2024-01-01","to":"2024-12-31","framework":"K2","signed_on":"2025-03-04","documents":{"annual_report":"/v1/documents/b9c4c326-292d-4f36-920c-101d85c98bb4.xhtml"},"source":{"dataset":"arsredovisningar","file":"2025/10_3.zip"}},{"from":"2023-01-01","to":"2023-12-31","framework":"K2","signed_on":"2024-03-20","documents":{"annual_report":"/v1/documents/89a2ddd5-3197-49a5-a953-15de5552d8bd.xhtml"},"source":{"dataset":"arsredovisningar","file":"2024/12_3.zip"}},{"from":"2022-01-01","to":"2022-12-31","framework":"K2","signed_on":"2023-03-31","documents":{"annual_report":"/v1/documents/9023129c-861e-4ea3-b047-dc4ff7cecddf.xhtml"},"source":{"dataset":"arsredovisningar","file":"2023/14_2.zip"}},{"from":"2021-01-01","to":"2021-12-31","framework":"K2","signed_on":"2022-03-22","documents":{"annual_report":"/v1/documents/ac289b8e-85b4-4028-b738-d993e4890e60.xhtml"},"source":{"dataset":"arsredovisningar","file":"2022/12_2.zip"}},{"from":"2020-01-01","to":"2020-12-31","framework":"K2","signed_on":"2021-03-15","documents":{"annual_report":"/v1/documents/853696b0-9d4b-4fad-bc10-13e23ef091a7.xhtml"},"source":{"dataset":"arsredovisningar","file":"2021/11_2.zip"}}],"latest_financials":{"from":"2025-01-01","to":"2025-12-31","scope":"company","currency":"SEK","net_sales":615267,"operating_profit":249293,"profit_after_financial_items":250811,"net_profit":146950,"total_assets":2344479,"current_assets":894479,"equity":1856495,"share_capital":50000,"unrestricted_equity":1806495,"untaxed_reserves":414000,"current_liabilities":73984,"cash":822441,"staff_costs":277389,"employees":1,"equity_ratio":0.932,"net_sales_growth":0.416,"source":{"annual_report":"2025-12-31","document":"/v1/documents/b6b30c57-4294-48e6-9d44-26f3a04e4338.xhtml"},"anchors":{"cash":{"text":"822 441","prefix":"Summa kassa och bank","suffix":"819 448"},"current_assets":{"text":"894 479"},"current_liabilities":{"text":"73 984"},"employees":{"text":"1","prefix":"anställda"},"equity":{"text":"1 856 495"},"equity_ratio":{"text":"93,2"},"net_profit":{"text":"146 950","suffix":"63"},"net_sales":{"text":"615 267","prefix":"Nettoomsättning"},"operating_profit":{"text":"249 293"},"profit_after_financial_items":{"text":"250 811"},"share_capital":{"text":"50 000","prefix":"utgång"},"staff_costs":{"text":"277 389"},"total_assets":{"text":"2 344 479","prefix":"TILLGÅNGAR"},"unrestricted_equity":{"text":"1 806 495","prefix":"950"},"untaxed_reserves":{"text":"414 000","prefix":"reserver"}}},"officers":{"annual_report":"2025-12-31","signed_on":"2026-05-09","signatories":[{"name":"P*****","role":"Styrelseledamot"}]}}